GLP-1RAs, such as liraglutide, inhibit the PINK1/Parkin pathway and restrain excessive mitophagy, protecting RGCs from a high glucose environment
Shelise Edwards, MD, FACEP
Diabetes mellitus (DM) is a group of metabolic diseases classified by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both
Impact of Helicobacter pylori on Alzheimers disease: what do we know so far
It is typically reserved for patients on higher maintenance doses who want the smallest possible injection volume
Semaglutide GLP-1 injections have also been shown to lower the risk of a stroke, heart attack, heart or blood vessel disease, or death in patients that are obese or more at risk for these conditions, and those with type 2 diabetes